Developing a universal vaccine for influenza
Official title: NIAID Influenza Data Processing and Communication Center: Universal Influenza Vaccine Research Activities
Funded at Digital Infuzion, INC. · NIH-11304132 · Data updated 2026-11-12
This study is working on a new flu vaccine that could protect against many different strains of the virus, using data from top research centers to find the best ways to make it happen.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Digital Infuzion, INC. NIH-funded |
| Lab location | 1 site (Rockville, UNITED STATES) |
| Project start | April 1, 2021 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $2,600,000 |
| NIH project number | 75N93021C00007-P00009-9999-2 |
| Project ID | NIH-11304132 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are at risk of influenza, including those with chronic health conditions, the elderly, and healthcare workers.
✕Less likely to help
Patients who are not at risk for influenza or those who have already received a specific flu vaccine may not benefit from this research.
What this research studies
This research focuses on creating a universal influenza vaccine by processing and analyzing data collected from various NIAID Centers of Excellence. The approach involves advanced data processing and communication techniques to enhance our understanding of influenza viruses and their responses. By leveraging comprehensive data, the research aims to identify effective strategies for vaccine development that could provide broader protection against multiple strains of the virus.
Why it matters
Potential benefit: If successful, this research could lead to a universal influenza vaccine that protects against various strains of the virus, reducing the incidence of flu and its complications.
How similar studies have gone: Other research efforts have shown promise in developing universal vaccines for influenza, indicating that this approach has potential for success.
Where this research is happening
-
Digital Infuzion, INC.
Rockville, United States Active
Researchers
- Principal investigator: Bour, Stephan — Digital Infuzion, INC.
- Study coordinator: Bour, Stephan
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Surveillance and preparedness for flu and other respiratory pathogens in Kenya
A US-based research grant aims to improve how Kenya detects and prepares for influenza and other respiratory diseases to protect people there and global health.
-
Enhanced Seasonal Influenza Vaccine Targeting Shared and Variable Viral Antigens
A new DNA-based influenza vaccine approach aims to provide both precise protection against circulating strains and broader defense against unexpected strains.
-
How the immune system responds to flu shots and flu infection
This project looks at how adults' immune systems react after flu shots or when they catch the flu to find why some people get better protection than others.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.